23andMe, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $ 3.5 billion. Then its fortunes began to sink. Fading interest in DNA kits – 23andMe’s main product –  was one driver. So was news last year that hackers stole ancestry data on […]